B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5
B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lowers the price target from $2 to $1.5.
Read original at benzingaStocks · News reference
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2
TD Cowen analyst Jonna Kim maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $2.5 to $2.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 7, 2026, 9:16 PM
- Checked
- Aug 7, 2026, 9:16 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Biote shares are trading lower after the company reported worse-than-expected Q2 financial results.
Read original at benzingaBiote FY2026 Revenue expected to be more than $175.000M vs $190.807M Est
Biote (NASDAQ:BTMD) FY2026 Revenue expected to be more than $175.000M vs $190.807M Est
Read original at benzinga